Old Web
English
Sign In
Acemap
>
authorDetail
>
M. Claire Holland
M. Claire Holland
GlaxoSmithKline
Medicine
Tolerability
Pharmacodynamics
Type 2 diabetes
Albiglutide
4
Papers
199
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Assessing the impact of Losmapimod on proteinuria in idiopathic focal segmental glomerulosclerosis
2020
Kidney International Reports
Debbie S. Gipson
Michelle A. Hladunewich
Richard A. Lafayette
John Sedor
Brad H. Rovin
Sean J. Barbour
Alan W. McMahon
J. Charles Jennette
Patrick H. Nachman
Robert N. Willette
Marcella G. Paglione
Feng Gao
Jorge Alfonso Ross Terres
Sue Vallow
M. Claire Holland
Kevin S. Thorneloe
Dennis L. Sprecher
Show All
Source
Cite
Save
Citations (3)
A randomized dose-finding study demonstrating the efficacy and tolerability of albiglutide in Japanese patients with type 2 diabetes mellitus
2014
Current Medical Research and Opinion
Yutaka Seino
Nobuya Inagaki
Hajime Miyahara
Inaha Okuda
Mark A. Bush
June Ye
M. Claire Holland
Susan L. Johnson
Eric Lewis
Hiromu Nakajima
Show All
Source
Cite
Save
Citations (25)
Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Albiglutide, a Long-Acting Glucagon-Like Peptide-1 Mimetic, in Patients with Type 2 Diabetes
2008
The Journal of Clinical Endocrinology and Metabolism
Jessica E. Matthews
Murray Stewart
Erika H. De Boever
Robert L. Dobbins
Rebecca J. Hodge
Susan E. Walker
M. Claire Holland
Mark A. Bush
Show All
Source
Cite
Save
Citations (160)
Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of Albiglutide, a Long-Acting GLP- 1 Mimetic, in Patients With Type 2 Diabetes
2008
The Journal of Clinical Endocrinology and Metabolism
Jessica E. Matthews
Murray Stewart
Erika H. De Boever
Robert L. Dobbins
Rebecca J. Hodge
Susan E. Walker
M. Claire Holland
Mark A. Bush
Show All
Source
Cite
Save
Citations (11)
1